Litcius/Paper detail

Cutaneous toxicities associated with epidermal growth factor receptor and mesenchymal epithelial transition factor dual blockade via bispecific antibody amivantamab

Isabel Arana, Grant J. Riew, Adam Rock, Vinod E. Nambudiri, Badri Modi, Connie R. Shi

2025Journal of the American Academy of Dermatology10 citationsDOI

Topics & Concepts

MedicineBlockadeEpidermal growth factor receptorAntibodyCancer researchBispecific antibodyReceptorImmunologyInternal medicineMonoclonal antibodyColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer ResearchCancer Diagnosis and Treatment
Cutaneous toxicities associated with epidermal growth factor receptor and mesenchymal epithelial transition factor dual blockade via bispecific antibody amivantamab | Litcius